(19)
(11) EP 4 798 200 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24805000.7

(22) Date of filing: 23.10.2024
(51) International Patent Classification (IPC): 
A61K 31/454(2006.01)
A61K 45/06(2006.01)
A61P 43/00(2006.01)
 A61K 31/445(2006.01)
A61K 9/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/454; A61K 45/06; A61K 31/445; A61P 43/00
 
C-Sets:
  1. A61K 31/445, A61K 2300/00;
  2. A61K 31/454, A61K 2300/00;
(86) International application number:
PCT/US2024/052537
(87) International publication number:
WO 2025/090588 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 24.10.2023 US 202363592675 P

(71) Applicant: Minerva Neurosciences, Inc.
Burlington, MA 01803 (US)

(72) Inventors:
  • LUTHRINGER, Remy
    1204 Geneva (CH)
  • NOEL, Nadine
    68210 Gildwiller (FR)
  • SCHMITT, Florent
    67150 Uttenheim (FR)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) ROLUPERIDONE FOR THE TREATMENT OF LYSOSOMAL STORAGE DISORDERS AND THEIR SYMPTOMS